Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thromboembolic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04446325
What this trial is testing

Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis

Who this might be right for
Lateral Amyotrophic SclerosisVenous Thrombo-embolic Desease
University Hospital, Brest 227
Early research (Phase 1)Study completedNCT05419635
What this trial is testing

Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function

Who this might be right for
Prevention of Thromboembolic EventsAtrial FibrillationAcute Myocardial Infarction+2 more
Bayer 27
Large-scale testing (Phase 3)Looking for participantsNCT05179876
What this trial is testing

A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

Who this might be right for
Hypertension, Pulmonary
Actelion 280
Not applicableEnded earlyNCT05572320
What this trial is testing

Platelet Function and Neurological Events

Who this might be right for
Stroke, AcuteCarotid Artery Diseases
Scientific Institute San Raffaele 650
Not applicableStudy completedNCT04616846
What this trial is testing

Thromboembolic Risk Screening in Patients With Cancer and COVID-19

Who this might be right for
Neoplasms MalignantCovid19Thromboembolism
Centre Antoine Lacassagne 88
Not applicableLooking for participantsNCT05340023
What this trial is testing

Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension

Who this might be right for
Chronic Thromboembolic Pulmonary Hypertension
Centre Hospitalier Universitaire de Saint Etienne 120
Not applicableStudy completedNCT03015025
What this trial is testing

Pharmacogenetic Dosage Algorithm for Acenocoumarol

Who this might be right for
Atrial FibrillationVenous ThrombosesCardiac Valve Disease
Instituto de Investigación Hospital Universitario La Paz 340
Testing effectiveness (Phase 2)Looking for participantsNCT05089227
What this trial is testing

Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

Who this might be right for
Prolonged AnticoagulationVenous Thromboembolic DiseaseAutoimmune Hemolytic Anemia
Centre Hospitalier Universitaire Dijon 72
Large-scale testing (Phase 3)Study completedNCT00038961
What this trial is testing

Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).

Who this might be right for
Thromboembolism
GlaxoSmithKline 1,309
Not applicableStudy completedNCT02117791
What this trial is testing

Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )

Who this might be right for
Hypertension, Pulmonary
Bayer 1,298
Not applicableUnknownNCT04405869
What this trial is testing

Thromboembolic Events in Severe COVID-19 Patients

Who this might be right for
Pulmonary Thromboembolism
University Hospital, Strasbourg, France 300
Very early researchLooking for participantsNCT06615596
What this trial is testing

Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)
China National Center for Cardiovascular Diseases 3,160
Not applicableLooking for participantsNCT07302620
What this trial is testing

HEPARINS: INTERFERENCE IN ARGATROBAN MEASUREMENT

Who this might be right for
Thromboembolic Disease
University Hospital, Strasbourg, France 70
Not applicableStudy completedNCT06037707
What this trial is testing

Thromboembolic Complications in COVID-19 Patients in Intensive Care Unit

Who this might be right for
COVID-19-Associated Thromboembolism
Ayse Zeynep Turan 484
Not applicableLooking for participantsNCT06418633
What this trial is testing

Variations in the Hemostatic System Induced by a Standardized Walking Test

Who this might be right for
Venous Thromboembolism
Centre Hospitalier Universitaire de Nīmes 94
Not applicableActive Not RecruitingNCT06855394
What this trial is testing

Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events

Who this might be right for
Atherosclerotic Vascular DiseaseCoronary Arterial Disease (CAD)Atherosclerosis of Coronary Artery+4 more
University of Florida 13,000
Testing effectiveness (Phase 2)Study completedNCT03522259
What this trial is testing

Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery

Who this might be right for
Bariatric Surgery
Insel Gruppe AG, University Hospital Bern 272
Testing effectiveness (Phase 2)Study completedNCT00306254
What this trial is testing

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

Who this might be right for
Venous Thrombosis
Pfizer 1,225
Not applicableStudy completedNCT00237328
What this trial is testing

Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery

Who this might be right for
Thrombosis
Duke University 1,015
Not applicableStudy completedNCT01715779
What this trial is testing

Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies

Who this might be right for
Hepatitis C
Novartis 22
Next Page